featured
Inhaled Budesonide for COVID-19 in High-Risk Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhaled Budesonide for COVID-19 in People at High Risk of Complications in the Community in the UK (PRINCIPLE): A Randomised, Controlled, Open-Label, Adaptive Platform Trial
Lancet 2021 Aug 10;[EPub Ahead of Print], LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, O Van Hecke, E Ogburn, PH Evans, NPB Thomas, MG Patel, D Richards, N Berry, MA Detry, C Saunders, M Fitzgerald, V Harris, M Shanyinde, S de Lusignan, MI Andersson, PJ Barnes, REK Russell, DV Nicolau, S Ramakrishnan, FDR Hobbs, CC ButlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.